Article citationsMore>>

Schuler, M., Awada, A., Harter, P., Canon, J.L., Possinger, K., Schmidt, M., et al. (2012) A Phase II Trial to Assess Efficacy and Safety to Afatinib in Extensively Pretreated Patients with HER2-Negative Metastatic Breast Cancer. B Breast Cancer Research and Treatment, 134, 1149-1159.
https://doi.org/10.1007/s10549-012-2126-1

has been cited by the following article: